This Article Full Text Full Text (PDF) All Versions of this Article: 38/4/1185    most recent 01.STR.0000259816.31370.44v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lemmens, R. Articles by Thijs, V. Search for Related Content PubMed PubMed Citation Articles by Lemmens, R. Articles by Thijs, V. Related Collections Acute Cerebral Hemorrhage Genetics of Stroke Computerized tomography and Magnetic Resonance Imaging Lipid and lipoprotein metabolism

(Stroke. 2007;38:1185.)
© 2007 American Heart Association, Inc.

Original Contributions

Association of Apolipoprotein E 2 With White Matter Disease but Not With Microbleeds

From Department of Neurology, University Hospitals Leuven, Leuven, Belgium.

Correspondence to Vincent Thijs, MD, PhD, Department of Neurology, University Hospitals Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. E-mail vincent.thijs{at}uz.kuleuven.ac.be

Background and Purpose— Apolipoprotein E (apoE) alleles (2 and 4) are associated with cerebral amyloid angiopathy, in which white matter disease and microbleeds are prominent features. The role of apoE in patients with microbleeds or white matter disease but no evidence of cerebral amyloid angiopathy has not been elucidated. We studied apoE alleles in relation to white matter disease and microbleeds in patients with transient ischemic attack or ischemic stroke.

Methods— We obtained brain MRI scans and apoE genotypes in 334 transient ischemic attack or ischemic stroke patients. Microbleeds were scored on a gradient echo MRI and white matter disease was examined on fluid attenuated inversion recovery MRI using a semiquantitative rating scale.

Results— Patients with moderate to severe white matter disease more frequently carried apoE 2 alleles (25.2% versus 11.3%, P=0.001), but not apoE 4 (26.6% in apoE 4 carriers versus 25.9%; P=0.98). Adjustment for traditional risk factors did not modify this relationship (odds ratio, 2.9; 95% confidence interval, 1.5 to 5.3). There was no association between the presence of microbleeds and the apoE 4 or apoE 2 alleles.

Conclusions— ApoE alleles do not exert a major influence on the development of microbleeds, but apoE 2 may be associated with development of moderate to severe white matter disease in transient ischemic attack and stroke patients.

Key Words: apolipoprotein E • genetics • white matter

This article has been cited by other articles:

				S. M. Gregoire, U. J. Chaudhary, M. M. Brown, T. A. Yousry, C. Kallis, H. R. Jager, and D. J. Werring The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds Neurology, November 24, 2009; 73(21): 1759 - 1766. [Abstract] [Full Text] [PDF]

				C. Cordonnier, G. M. Potter, C. A. Jackson, F. Doubal, S. Keir, C. L.M. Sudlow, J. M. Wardlaw, and R. A.-S. Salman Improving Interrater Agreement About Brain Microbleeds: Development of the Brain Observer MicroBleed Scale (BOMBS) Stroke, January 1, 2009; 40(1): 94 - 99. [Abstract] [Full Text] [PDF]

				APOE Genotype and MRI Markers of Small Vessel Disease Journal Watch Neurology, June 5, 2007; 2007(605): 1 - 1. [Full Text]